Retatrutide (GLP-3R)
Synthetic Triple Receptor Agonist
You save from $46.00 Stock the Shelf applied automatically at checkout — no code needed
Direct-source pricing: Solira works through manufacturing partnerships to reduce reseller markup while maintaining independent third-party testing and lot-specific COA verification.
Estimated delivery Wed, Oct 14 – Tue, Oct 20
Quick facts
- Type
- Synthetic GLP-1/GIP/glucagon triple receptor agonist
- Purity
- HPLC-verified (see COA)
- Testing
- Third-party HPLC + mass spectrometry
- Form
- Lyophilized powder
- Shipping
- Same-day (orders before 3 PM ET)
- Use
- In-vitro laboratory research only
The Solira Take
GLP-3R is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Studied in published preclinical work on multi-receptor incretin-pathway research.
Research reference
COA / Testing
Every batch of product sold by Solira undergoes independent third-party analytical testing to verify identity and purity, performed by Chromate.
- HPLC purity analysis — confirms compound purity
- Mass spectrometry — identity confirmation via molecular weight verification
- Lot-specific documentation — each COA corresponds to the specific manufacturing lot
Tested lot TR6026 (20 mg) — reference for all GLP-3R concentrations
The full lab results for this lot are published in text on its Certificate of Analysis page. Each figure is also independently verifiable at Chromate, the testing laboratory.
Description
Retatrutide (GLP-3R), also referenced as ION-3R, is a synthetic triple agonist targeting GLP-1, GIP, and glucagon receptors, supplied as a lyophilized powder for laboratory research. The compound represents a novel class of multi-receptor incretin research tools.
Supplied for in vitro research and preclinical investigation only. Independently verified by HPLC and mass spectrometry.
Product Specs
Research Applications
- Investigated in preclinical models for concurrent activation of GLP-1, GIP, and glucagon receptors.
- Studied in in vitro systems for energy expenditure pathway signaling.
- Used in laboratory research examining hepatic lipid metabolism in cellular models.
- Evaluated in controlled preclinical settings for comparative incretin receptor pharmacology.
Storage & Handling
Store sealed, dry, and protected from light.
Long-term storage: -20°C recommended.
Short-term storage: 2-8°C acceptable.
Reconstitution: Use sterile technique with bacteriostatic water.
Post-reconstitution: Stable up to 30 days at 2-8°C.
All handling instructions are intended for laboratory use only.
Sold to qualified researchers for laboratory use only. These products have not been evaluated by the FDA, are not intended to diagnose, treat, cure or prevent any disease, and are not for human, veterinary, or food use in any form. The purchaser is responsible for the lawful and proper use of any compound purchased.
